Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, July 2000, p. 706-709, Vol. 7, No. 4
HIV Immunology and Diagnostics Branch,
Division of AIDS, STD, and TB Laboratory Research, National Center
for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, Georgia 30333,1 and
Division of Microbiology, Institute of Tropical Medicine,
Antwerp, Belgium2
Received 16 February 2000/Returned for modification 1 April
2000/Accepted 12 April 2000
Cross-species transmission has been shown to play an important role
in the emergence of human retroviruses. We developed a generic enzyme
immunoassay using synthetic peptides from gp41 and C2V3 consensus
sequences (human immunodeficiency virus [HIV] type 1 [HIV-1]
groups M, O, and N and the homologous region of simian immunodeficiency
virus [SIV] strains from chimpanzees [SIVcpz], SIVcpzGAB1 and
SIVcpzANT) to detect divergent HIV and SIV. A cocktail of peptides from
gp41 and C2V3 (M-O) detected all HIV-1 group M and O sera and showed
cross-reactivity with SIVcpz sera. Further, a mixture of C2V3 peptides
(GAB1-ANT) failed to detect HIV-1 infections but reacted with all
SIVcpz sera, allowing discrimination of SIVcpz from HIV-1 infections.
Since most SIVcpz sera cross-reacted with HIV-1 peptides, we next
evaluated SIVcpz serum reactivity with rapid tests for HIV-1/2.
SIVcpzANT and SIVcpzUS sera reacted with the Sero-strip and Multispot
assays. Both tests are sensitive in detecting group M (97 100%,
respectively), although Multispot has lower sensitivity for group O
detection (67%) than does Sero-strip (100%). The limited volume and
time required to perform these assays make them a generic tool for
field screening. The env peptide-based assay and rapid
tests should allow for the identification of emerging variants of HIV
and SIV.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Serological Detection of Infection with Diverse Human and Simian
Immunodeficiency Viruses Using Consensus env
Peptides
*
Corresponding author. Mailing address: HIV Immunology
and Diagnostics Branch, DASTLR/NCID, Centers for Disease Control and Prevention, Mail Stop D12, 1600 Clifton Rd., Atlanta, GA 30333. Phone:
(404) 639-1036. Fax: (404) 639-2660. E-mail: rbl3{at}cdc.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»